Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
Clinical trial NCT01223235 · COMPLETED
Trial details
- NCT number
- NCT01223235
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2017-09-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.